User:Mr. Ibrahem/Guselkumab

Guselkumab, sold under the brand name Tremfya, is a medication used to treat plaque psoriasis. It is used for moderate to severe disease. It is given by injection under the skin.

Common side effects include upper respiratory tract infections. Other side effects may include infection, headache, joint pain, liver problems, and decreased effectiveness of vaccines. Safety in pregnancy is unclear. It is a monoclonal antibody which attaches to and blocks interleukin-23.

Guselkumab was approved for medical use in the United States and Europe in 2017. In the United Kingdom it costs the NHS about £2,250 per 100 mg as of 2021. This amount in the United States is about 11,600 USD.